A phase 3 clinical trial of BonoFill (Human-adipose-derived-somatic-cell-therapy).
Latest Information Update: 25 Jul 2025
At a glance
- Drugs Human adipose-derived somatic cell therapy Bonus BioGroup (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
Most Recent Events
- 25 Jul 2025 New trial record
- 14 Jul 2025 According to Bonus Biogroup media release, The company plans to initiate a Phase 3 study for the same indication in 2026. Additionally, a Phase 2 clinical trial is underway to treat large bone defects in the limbs.